Cutaneous Hypersensitivity and Desensitization to Mechlorethamine in Patients with Mycosis Fungoides Lymphoma
Authors: DONALD S. WALDORF
Journal: Annals of Internal Medicine (1967)

Article1 August 1967Cutaneous Hypersensitivity and Desensitization to Mechlorethamine in Patients with Mycosis Fungoides LymphomaDONALD S. WALDORF, M.D., HARLEY A. HAYNES, M.D., EUGENE J. VAN SCOTT, M.D.DONALD S. WALDORF, M.D., HARLEY A. HAYNES, M.D., EUGENE J. VAN SCOTT, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-67-2-282 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptMechlorethamine (nitrogen mustard, HN2) has been employed in the therapy of mycosis fungoides lymphoma for many years, most often by the intravenous route (1, 2). More recently, the agent has been shown to be effective when applied topically in nonvesicant doses to cutaneous lesions of the disease (3-7). Although development of cutaneous sensitivity to the drug in normal individuals is well-known (5, 8), the frequency of sensitization in patients with mycosis fungoides is alleged to be low (5).The clinical study reported herein was prompted by the observation that allergic contact dermatitis to HN2was induced in 11 of 16...References1. HENSTELLTOBERG HHJN: Treatment of mycosis fungoides with nitrogen mustard. J. Invest. Derm. 8: 183, 1947. CrossrefMedlineGoogle Scholar2. WRIGHTLYONSWALKERGOLOMBGUMPORTMEDREK JCMMDGFMSLTJ: Observations on the use of cancer chemotherapeutic agents in patients with mycosis fungoides. Cancer 17: 1045, 1964. CrossrefMedlineGoogle Scholar3. WILKINSONHASERICK RJ: Topical nitrogen mustard therapy in mycosis fungoides. Arch. Derm. (Chicago) 82: 440, 1960. Google Scholar4. VINEYARDMITCHELL WRDE: Local therapy of mycosis fungoides with cytotoxic agents. A case report. Arch. Derm. (Chicago) 84: 928, 1961. CrossrefMedlineGoogle Scholar5. MADISONHASERICK JFJR: Topically applied mechlorethamine on 12 dermatoses. Arch. Derm. (Chicago) 86: 663, 1962. CrossrefGoogle Scholar6. WATSONWILKINSONCRAIG JIRDGE: Topical nitrogen mustard in cutaneous lymphosarcoma (mycosis fungoides). Canad. Med. Ass. J. 87: 1284, 1962. MedlineGoogle Scholar7. SIPOS K: Painting treatment of nitrogen mustard in mycosis fungoides. Dermatologica (Basel) 130: 3, 1965. CrossrefMedlineGoogle Scholar8. NEXMAND PH: Skin sensitization to nitrogen mustard with reference to the cytologic differences between primary irritant and eczematous reactions. Dermatologica (Basel) 100: 73, 1950. CrossrefGoogle Scholar9. EPSTEINKLIGMAN WLAM: Transfer of allergic contact-type delayed sensitivity in man. J. Invest. Derm. 28: 291, 1957. CrossrefMedlineGoogle Scholar10. BLAYLOCKCLENDENNINGCARBONEVAN SCOTT WKWEPPEJ: Normal immunologic reactivity in patients with the lymphoma mycosis fungoides. Cancer 19: 233, 1966. CrossrefMedlineGoogle Scholar11. CLENDENNINGVAN SCOTT WEEJ: Skin autografts and homografts in patients with the lymphoma mycosis fungoides. Cancer Res. 25: 1844, 1965. Google Scholar12. GOLUMBICFRUTONBERGMAN CJSM: Chemical reactions of the nitrogen mustard gases. I. The transformation of methyl bis-(β-chloroethyl) amine. J. Org. Chem. 11: 518, 1946. CrossrefGoogle Scholar13. GOLUMBICBERGMAN CM: Chemical reactions of the nitrogen mustard gases. II. The composition of aged unbuffered solutions of methyl bis(β-chloroethyl) amine. Ibid., p. 536. Google Scholar14. INCHMCCREDIE WRJA: Effect of aging aqueous nitrogen mustard on white blood cell count, body weight, and Walker 256 tumor in the rat. Canad. J. Biochem. 41: 417, 1963. MedlineGoogle Scholar15. STODDART JC: Nickel sensitivity as a cause of infusion reactions. Lancet 2: 741, 1960. CrossrefGoogle Scholar16. SHELLEYRESNIK WBSS: Basophil degranulation induced by oral poison ivy antigen. Arch. Derm. (Chicago) 92: 147, 1965. CrossrefGoogle Scholar17. SULZBERGER MB: Hypersensitiveness to neoarsphenamine in guinea pigs: experiments in prevention and in desensitization. Arch. Derm. (Chicago) 20: 669, 1929. Google Scholar18. CHASE MW: Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. Med. 61: 257, 1946. CrossrefMedlineGoogle Scholar19. SMITH RT: Immunological tolerance of non-living antigens, in Advances in Immunology, vol. 1. Academic Press, Inc., Publishers, New York, 1961, pp. 67-129. Google Scholar20. BATTISTOMILLER JRJ: Immunological unresponsiveness produced in adult guinea pigs by parenteral introduction of minute quantities of hapten or protein antigen. Proc. Soc. Exp. Biol. Med. 111: 111, 1962. CrossrefMedlineGoogle Scholar21. JONESLESKOWITZ VES: Immunochemical study of antigenic specificity in delayed hypersensitivity. IV. The production of unresponsiveness to delayed hypersensitivity with a single antigenic determinant. J. Exp. Med. 122: 505, 1965. CrossrefMedlineGoogle Scholar22. BORELFAUCONNETMIESCHER YMPA: Selective suppression of delayed hypersensitivity by the induction of immunologic tolerance. J. Exp. Med. 123: 585, 1966. CrossrefMedlineGoogle Scholar23. DVORAKFLAX HFMH: Immunologic unresponsiveness in the adult guinea pig. II. The kinetics of unresponsiveness. J. Immun. 96: 546, 1966. MedlineGoogle Scholar24. DEWECKFREY ALJR: Immunotolerance to simple chemicals, in Monographs in Allergy, vol. 1. American Elsevier Publishing Co., Inc., New York, 1966, pp. 71-76. Google Scholar25. SULZBERGERBAERKANOFLOWENBERG MBRLAC: Skin sensitization to vesicant agents of chemical warfare. J. Invest. Derm. 8: 363, 1947. Google Scholar26. KLIGMAN AM: Hyposensitization against rhus dermatitis. Arch. Derm. (Chicago) 78: 47, 1958. CrossrefGoogle Scholar27. LOWNEY ED: Immunologic unresponsiveness appearing after topical application of contact sensitizers to the guinea pig. J. Immun. 95: 397, 1965. MedlineGoogle Scholar28. PARK RG: Sulphonamide allergy, the persistence of desensitization. Brit. Med. J. 2: 816, 1944. CrossrefMedlineGoogle Scholar29. MORRIS-OWEN RM: Treatment of contact dermatitis due to handling antibiotics. Brit. Med. J. 1: 654, 1956. CrossrefMedlineGoogle Scholar30. FREYDEWECKGELEICK JRALH: Inhibition of the contact reaction to dinitrochlorobenzene by intravenous injection of dinitrobenzene sulfonate in guinea pigs sensitized to dinitrochlorobenzene. J. Invest. Derm. 42: 189, 1964. CrossrefMedlineGoogle Scholar31. LESKOWITZJONES SVE: Immunochemical study of antigenic specificity in delayed hypersensitivity. 3. Suppression of hapten-specific delayed hypersensitivity by conjugates of varying size. J. Immun. 95: 331, 1966. Google Scholar32. FREYDEWECKGELEICK JRALH: Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. IV. Desensitization to NEO. Int. Arch. Allerg. 30: 521, 1966. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: DONALD S. WALDORF, M.D.; HARLEY A. HAYNES, M.D.; EUGENE J. VAN SCOTT, M.D.Affiliations: Bethesda, MarylandFrom the Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md.Requests for reprints should be addressed to Harley A. Haynes, M.D., Dermatology Branch, Bldg. 10, Room 12N-238, National Institutes of Health, Bethesda, Md. 20014. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAlkylating AgentsTopical nitrogen mustard ointment with occlusion for Langerhans' cell histiocytosis of the scalpCutaneous T-cell lymphomasDetection of Low-Level Tumor Cells in Allergic Contact Dermatitis Induced by Mechlorethamine in Patients with Mycosis FungoidesAtypical Cutaneous Changes after Topical Treatment with Nitrogen Mustard in Patients with Mycosis FungoidesTopical Treatment of Early Cutaneous T-cell LymphomaMycosis fungoides and the Sézary syndrome: Pathology, staging, and treatmentComparison of the Nuclear Contour Index (NCI) and T cell Subsets of Erythematous, Plaque and Tumor Lesions in Patients with Mycosis Fungoides (MF)Cutaneous Side Effects of Cancer ChemotherapyTreatment of Parapsoriasis and Mycosis Fungoides: The Role of Psoralen and Long-Wave Ultraviolet Light A (PUVA)Ointment-based mechlorethamine treatment for mycosis fungoidesCutaneous complications of chemotherapeutic agentsCutaneous T-cell lymphoma: A reviewFailure of periodic ultraviolet radiation treatments to prevent sensitization to nitrogen mustard: a case reportREFERENCESMycosis fungoidesDefective monocyte chemotaxis in mycosis fungoides. Lack of essential helper lymphocytesTopical Mechlorethamine For PsoriasisMucocutaneous side effects of cancer chemotherapyProliferative Disorders of the T-Cell SeriesNEW ADVANCES IN CONTACT DERMATITISImmunotherapy of Human CancerCELL-MEDIATED IMMUNITY IN MYCOSIS FUNGOIDES*Non-Hodgkin Lymphomas (Lymphosarcoma, Reticulosarcoma)Lymphocyte transformation in mycosis fungoidesGenetic control of contact sensitivity in mice: Effect ofH-2 and nonH-2 lociMycosis fungoides—a disease of antigen persistenceInduction of delayed hypersensitivity to nitrogen mustard in the guinea-pigComplete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic toleranceFailure to Induce Immune Tolerance to Nitrogen Mustard. Intravenous Administration Preceding Topical use in Patients with PsoriasisClinical immunologic responsiveness in malignant disease.I. Delayed hypersensitivity reaction and the effect of cytotoxic drugsAlterations of lesions of mycosis fungoides lymphoma by direct imposition of delayed hypersensitivity reactions 1 August 1967Volume 67, Issue 2Page: 282-290KeywordsContact dermatitisDermatologyDrugsHypersensitivityLesionsLymphomaMechlorethamine ePublished: 1 December 2008 Issue Published: 1 August 1967 PDF downloadLoading ...